Activities of trovafloxacin, gatifloxacin, clinafloxacin, sparfloxacin, levofloxacin, and ciprofloxacin against penicillin-resistant Streptococcus pneumoniae in an in vitro infection model.
about
Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.What do we really know about antibiotic pharmacodynamics?In vitro pharmacodynamic models to determine the effect of antibacterial drugs.Activities of moxifloxacin against, and emergence of resistance in, Streptococcus pneumoniae and Pseudomonas aeruginosa in an in vitro pharmacokinetic model.Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model.
P2860
Activities of trovafloxacin, gatifloxacin, clinafloxacin, sparfloxacin, levofloxacin, and ciprofloxacin against penicillin-resistant Streptococcus pneumoniae in an in vitro infection model.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Activities of trovafloxacin, g ...... n an in vitro infection model.
@ast
Activities of trovafloxacin, g ...... n an in vitro infection model.
@en
type
label
Activities of trovafloxacin, g ...... n an in vitro infection model.
@ast
Activities of trovafloxacin, g ...... n an in vitro infection model.
@en
prefLabel
Activities of trovafloxacin, g ...... n an in vitro infection model.
@ast
Activities of trovafloxacin, g ...... n an in vitro infection model.
@en
P2860
P1476
Activities of trovafloxacin, g ...... n an in vitro infection model.
@en
P2093
E Hershberger
P2860
P304
P356
10.1128/AAC.44.3.598-601.2000
P407
P577
2000-03-01T00:00:00Z